Morley, Andrew,Miller, Rebecca,La Thangue, Nicholas
申请号：
AU2018235139
公开号：
AU2018235139A1
申请日:
2018.03.16
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present disclosure relates to compounds suitable for the inhibition of protein arginine methyl-transferase (PRMT), in particular PRMT5. These compounds may be for use as therapeutic agents, in particular, agents for use in the treatment and/or prevention of proliferative diseases, such as cancer.
